Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Feb 6;10(2):e1003898.
doi: 10.1371/journal.ppat.1003898. eCollection 2014 Feb.

Lectin-like bacteriocins from Pseudomonas spp. utilise D-rhamnose containing lipopolysaccharide as a cellular receptor

Affiliations

Lectin-like bacteriocins from Pseudomonas spp. utilise D-rhamnose containing lipopolysaccharide as a cellular receptor

Laura C McCaughey et al. PLoS Pathog. .

Abstract

Lectin-like bacteriocins consist of tandem monocot mannose-binding domains and display a genus-specific killing activity. Here we show that pyocin L1, a novel member of this family from Pseudomonas aeruginosa, targets susceptible strains of this species through recognition of the common polysaccharide antigen (CPA) of P. aeruginosa lipopolysaccharide that is predominantly a homopolymer of D-rhamnose. Structural and biophysical analyses show that recognition of CPA occurs through the C-terminal carbohydrate-binding domain of pyocin L1 and that this interaction is a prerequisite for bactericidal activity. Further to this, we show that the previously described lectin-like bacteriocin putidacin L1 shows a similar carbohydrate-binding specificity, indicating that oligosaccharides containing D-rhamnose and not D-mannose, as was previously thought, are the physiologically relevant ligands for this group of bacteriocins. The widespread inclusion of d-rhamnose in the lipopolysaccharide of members of the genus Pseudomonas explains the unusual genus-specific activity of the lectin-like bacteriocins.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. CPA production correlates with pyocin L1 killing.
(A) Inhibition of growth of P. aeruginosa E2 and tolerant mutants M4 and M11 by pyocin L1, as shown by a soft agar overlay spot-test. 5 µl of purified pyocin L1 (1.5 mg ml−1) was spotted onto a growing lawn of cells. Clear zones indicate cell death. (B) Expression of CPA by P. aeruginosa E2 and tolerant mutants, visualised by immunoblotting with the CPA specific antibody N1F10. (C) Inhibition of growth of P. aeruginosa PAO1 and PAO1 wzm and wzt mutants by pyocin L1 (details as for A). (D) Expression of CPA by PAO1 and wzm and wzt strains (details as for B).
Figure 2
Figure 2. Pyocin L1 binds strongly to CPA from P. aeruginosa PAO1.
(A) ITC binding isotherm of pyocin L1 (150 µM) titrated into isolated LPS-derived polysaccharide (1 mg ml−1) from wild-type P. aeruginosa PAO1. Strong, saturable heats were observed indicative of a strong interaction. Curve fitted with a single binding site model. (B) ITC isotherm of pyocin L1 (150 µM) titrated into isolated LPS-derived polysaccharide (1 mg ml−1) from PAO1 wzt. No saturable binding isotherm was observed.
Figure 3
Figure 3. Pyocin L1 shows specificity for d-rhamnose compared with d-mannose.
(A) ITC binding isotherm of d-rhamnose (50 mM) titrated into pyocin L1 (100 µM). Weakly saturable heats were observed, indicative of binding with modest affinity (Kd ∼5–10 mM). (B) ITC binding isotherm of d-mannose (50 mM) titrated into pyocin L1 (100 µM). Small-weakly saturable heats were observed, indicative of very weak interaction (Kd ∼50 mM). Titration of monomeric sugars into 15N-labelled pyocin L1, monitored using 1H-15N HSQC NMR spectroscopy. Shifts within spectra were converted to chemical shift perturbation (CSP) values using equation Δppm = √ [ΔδHN+(ΔδNN)2]. CSP values are plotted against sugar concentration in (C) and (E) and visualised in (D) and (F). Peak positions, which correspond to backbone amide signals, at selected sugar concentrations (blue: no sugar, green: 60 mM, red: 100 mM) are shown. Perturbation of peak position (ppm) is indicative of association between ligand and protein molecules in solution.
Figure 4
Figure 4. Crystal structure of pyocin L1 reveals tandem MMBL domains and sugar-binding motifs.
(A) Ribbon diagram of structure of pyocin L1 in complex with α-d-rhamnose, amino acids 2-256. N-terminal domain (green), C-terminal domain (pink), C-terminal extension (red), α-d-rhamnose (spheres) and sugar binding sites containing the conserved or partially conserved QxDxNxVxY motif are highlighted (blue) and are designated N1, N2 and C1, C2 according to order of appearance in the primary sequence of the N- and C-terminal domains, respectively. Pyocin L1 residues involved in hydrogen bonding with α-d-rhamnose are shown in stick representation. (B) Sequence and secondary structure (β-sheets = arrows, α-helices = coils) of pyocin L1 with colours corresponding to the structure in (A). Residues conserved in sugar binding motifs are shown in bold. (C) Structural alignment of pyocin L1 (green) and putidacin L1 (blue) based on N-terminal MMBL domain in wall-eyed stereo. (D) Structural alignment of pyocin L1 (green) and Allium sativum agglutinin (1BWU) (pink) based on N-terminal MMBL domain in wall-eyed stereo.
Figure 5
Figure 5. C-terminal MMBL-sugar binding motifs of pyocin L1 bind d-rhamnose and d-mannose.
Electron density (at 1.3 σ) with fitted stick model of pyocin L1 MMBL-sugar binding site C1 with: (A) d-rhamnose (XXR), (C) d-mannose (BMA), (E) no bound sugar, and sugar binding site C2 with: (B) d-rhamnose, (D) d-mannose, (F) no bound sugar. For clarity, electron density is clipped to within 1.5 Å of visible atoms.
Figure 6
Figure 6. Hydrogen-bonding interactions between pyocin L1 MMBL sugar-binding motif C1 with d-rhamnose and d-mannose.
Hydrogen bonds between protein side chains with (A) d-rhamnose and (B) d-mannose are shown; all distances are in Å.
Figure 7
Figure 7. Binding of the CPA at the C-terminal sugar binding motifs, C1 and C2, is critical to pyocin L1 cytotoxicity.
ITC binding isotherms of (A) wild-type (B) D180A (C) D150A and (D) D150A/D180A pyocin L1 all at (100 µM) titrated into isolated LPS-derived polysaccharide (1 mg ml−1) from wild-type P. aeruginosa PAO1. Fit to a single binding site model is shown. (E) Spot tests to determine cytotoxic activity of wild-type and pyocin L1 variants against of P. aeruginosa PAO1. Purified protein (starting concentration 400 µg ml−1 with 2-fold sequential dilutions) was spotted onto a growing lawn of P. aeruginosa PAO1. Clear zones indicate pyocin L1 cytotoxicity.
Figure 8
Figure 8. Putidacin L1 binds strongly to LPS-derived polysaccharides from susceptible but not tolerant or resistant P. syringae isolates.
ITC isotherm of LPS-derived polysaccharides (3 mg ml−1) from strains highly sensitive to putdacin L1: (A) P. syringae LMG 2222, (B) P. syringae LMG 5456 titrated into putidacin L1 (60 µM). Large, saturable heats are indicative of binding. LPS-derived polysaccharides (3 mg ml−1) from strains non-sensitive to putidacin L1: (C) P. syringae NCPPB 2563, (D) P. syringae DC3000, or highly tolerant (E) P. syringae LMG 1247 to putidacin L1, show no heats of binding when titrated into putidacin L1 (60 µM).

References

    1. Gorkiewicz G (2009) Nosocomial and antibiotic-associated diarrhoea caused by organisms other than Clostridium difficile. International Journal of Antimicrobial Agents 33: S37–S41. - PubMed
    1. Carroll KC, Bartlett JG (2011) Biology of Clostridium difficile: Implications for Epidemiology and Diagnosis. Annual Review of Microbiology 65: 501–521. - PubMed
    1. Manichanh C, Borruel N, Casellas F, Guarner F (2012) The gut microbiota in IBD. Nature Reviews Gastroenterology & Hepatology 9: 599–608. - PubMed
    1. Qin J, Li Y, Cai Z, Li S, Zhu J, et al. (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490: 55–60. - PubMed
    1. Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, et al. (2012) Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482: 179–U167. - PMC - PubMed

Publication types